These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 20806987)

  • 1. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.
    McIntyre RS; Park KY; Law CW; Sultan F; Adams A; Lourenco MT; Lo AK; Soczynska JK; Woldeyohannes H; Alsuwaidan M; Yoon J; Kennedy SH
    CNS Drugs; 2010 Sep; 24(9):741-53. PubMed ID: 20806987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome.
    Kemp DE; Ismail-Beigi F; Calabrese JR
    Am J Psychiatry; 2009 May; 166(5):619. PubMed ID: 19411385
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatigue as a core symptom in major depressive disorder: overview and the role of bupropion.
    Pae CU; Lim HK; Han C; Patkar AA; Steffens DC; Masand PS; Lee C
    Expert Rev Neurother; 2007 Oct; 7(10):1251-63. PubMed ID: 17939764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation antidepressants for depression in adults.
    Seehusen DA; Sheridan R
    Am Fam Physician; 2013 Nov; 88(10):687-9. PubMed ID: 24364484
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis.
    Gartlehner G; Hansen RA; Morgan LC; Thaler K; Lux L; Van Noord M; Mager U; Thieda P; Gaynes BN; Wilkins T; Strobelberger M; Lloyd S; Reichenpfader U; Lohr KN
    Ann Intern Med; 2011 Dec; 155(11):772-85. PubMed ID: 22147715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choosing a second generation antidepressant for treatment of major depressive disorder.
    Lester H; Gilbody S
    BMJ; 2012 Feb; 344():e1014. PubMed ID: 22334542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Depressions: current concepts].
    Corruble E
    Encephale; 2010 Dec; 36 Suppl 5():S104-7. PubMed ID: 21211627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine withdrawal syndrome: report of seven cases in Trinidad.
    Baboolal NS
    J Clin Psychopharmacol; 2004 Apr; 24(2):229-31. PubMed ID: 15206672
    [No Abstract]   [Full Text] [Related]  

  • 9. Tardive dyskinesia associated with long-term administration of escitalopram and itopride in major depressive disorder.
    Park YM; Lee HJ; Kang SG; Choo CS; Cho JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):380-1. PubMed ID: 19121360
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension induced by regular doses of milnacipran: a case report.
    de Toledo Ferraz Alves TC; Guerra de Andrade A
    Pharmacopsychiatry; 2007 Jan; 40(1):41-2. PubMed ID: 17327962
    [No Abstract]   [Full Text] [Related]  

  • 12. Venlafaxine: new preparation. Just another antidepressant.
    Prescrire Int; 1998 Aug; 7(36):112-4. PubMed ID: 10342950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early weight gain predicts later metabolic syndrome in depressed patients treated with antidepressants: Findings from the METADAP cohort.
    El Asmar K; Fève B; Colle R; Trabado S; Verstuyft C; Gressier F; Vievard A; Haffen E; Polosan M; Ferreri F; Falissard B; Chanson P; Becquemont L; Corruble E
    J Psychiatr Res; 2018 Dec; 107():120-127. PubMed ID: 30390577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression.
    Wand AP
    Aust N Z J Psychiatry; 2012 Feb; 46(2):178. PubMed ID: 22311539
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of Escitalopram-Induced Sweating With Citalopram.
    Kolli V; Rainville CT
    Prim Care Companion CNS Disord; 2017 Apr; 19(2):. PubMed ID: 28426928
    [No Abstract]   [Full Text] [Related]  

  • 16. Making the best use of available evidence: the case of new generation antidepressants: a response to: are all antidepressants equal?
    Barbui C; Cipriani A; Furukawa TA; Salanti G; Higgins JP; Churchill R; Watanabe N; Nakagawa A; Omori IM; Geddes JR
    Evid Based Ment Health; 2009 Nov; 12(4):101-4. PubMed ID: 19854766
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
    Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
    J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
    Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
    J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine-associated serotonin syndrome and manic episode in a geriatric depressive patient.
    Liau CH; Shen WW; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):121-2. PubMed ID: 16472373
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.
    Cuomo A; Ballerini A; Bruni AC; Decina P; Di Sciascio G; Fiorentini A; Scaglione F; Vampini C; Fagiolini A
    Riv Psichiatr; 2019; 54(4):137-149. PubMed ID: 31379379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.